PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in the development of products with the potential for earlier and more effective detection, diagnosis and monitoring of brain disorders, today announced that Daniel M. Skovronsky, M.D., Ph.D., Founder and CEO, will present at the 21st Annual Piper Jaffray Health Care Conference. The conference will be held December 1-2, 2009 at the New York Palace Hotel in New York City.